Filter
3554
Filtered Results: 3554
Text search:
receiving
medicines
Featured
Recommendations
317
New Publications
1007
Language
Document type
No document type
2187
Studies & Reports
536
Guidelines
408
Manuals
176
Strategic & Response Plan
100
Training Material
49
Fact sheets
46
Situation Updates
32
Infographics
15
Resource Platforms
4
Brochures
1
Countries / Regions
India
205
Kenya
117
Global
109
South Africa
100
Ethiopia
85
Nepal
82
Uganda
76
Tanzania
70
Western and Central Europe
65
Bangladesh
62
Sierra Leone
61
Malawi
61
Liberia
60
Nigeria
60
Zambia
57
Myanmar / Burma
54
Ukraine
53
Africa
51
Syria
50
Latin America and the Carribbean
49
Ghana
47
Rwanda
45
Zimbabwe
37
Namibia
36
Congo, Democratic Republic of
31
Philippines
26
Mozambique
24
Eastern Europe
24
Cambodia
23
Lesotho
22
South–East Asia Region
22
Venezuela
22
Asia
20
Senegal
19
East and Southern Africa
16
Botswana
15
West and Central Africa
15
Russia
15
South Sudan
13
Eswatini/ Swaziland
13
Germany
12
Burkina Faso
11
Lebanon
11
Yemen
11
Guinea
10
Pakistan
10
Indonesia
10
Moldova
10
Cameroon
9
Middle East and North Africa
9
Vietnam
9
USA
8
Haiti
8
Colombia
8
Jordan
7
Afghanistan
7
Brazil
7
Sri Lanka
7
Eastern Europe and Central Asia
7
Sudan
6
Western Pacific Region
6
Albania
6
Laos
6
Tajikistan
6
Georgia
6
Thailand
5
Benin
5
Central African Republic
5
Peru
5
North Macedonia
5
Somalia
4
Paraguay
4
Poland
4
Southern Africa
4
Iran
4
Iraq
3
Egypt
3
Hungary
3
Burundi
3
Madagascar
3
Palestine
3
Romania
3
Jamaica
3
United Kingdom
3
Mali
2
Saudi Arabia
2
Turkey
2
Chad
2
Gambia
2
China
2
Argentina
2
Mexico
2
Bhutan
2
Timor Leste/ East Timor
2
Estonia
2
Lithuania
2
Kyrgyzstan
2
Kazakhstan
2
Mauritius
2
Belarus
2
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Togo
1
Singapore
1
Papua New Guinea
1
Serbia
1
El Salvador
1
Bolivia
1
Greece
1
Libya
1
Chile
1
Other region
1
Fiji
1
Djibouti
1
Armenia
1
Mongolia
1
Canada
1
Qatar
1
Bulgaria
1
Slovakia
1
North America
1
Turkmenistan
1
Norway
1
Portugal
1
South Korea
1
Authors & Publishers
Publication Years
Category
Countries
1455
Clinical Guidelines
335
Women & Child Health
179
Public Health
178
Key Resources
90
Capacity Building
77
Pharmacy & Technologies
28
Annual Report MEDBOX
3
Toolboxes
HIV
440
Mental Health
258
TB
254
COVID-19
236
Caregiver
106
Conflict
105
Disability
102
Pharmacy
92
AMR
89
Ebola
88
Refugee
62
Rapid Response
58
NCDs
57
NTDs
56
Global Health Education
46
Planetary Health
42
Natural Hazards
33
Health Financing Toolbox
28
Social Ethics
18
Specific Hazards
13
Cholera
10
Polio
10
Zika
6
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality ... for the population. To fulfill its mandate, DPMED aims to strengthen its regulatory capacity, including the issuance of licenses to pharmaceutical establishments and the registration of pharmaceutical products. Benin’s current registration system shares core concerns that are common to most developing countries, notably the capacity to evaluate and monitor the security, efficacy, and quality of medicines and other health products. It is currently characterized by 1) poor or inadequate traceability of records or regulations (example: a product’s marketing authorization [MA] is often hard to find); 2) lack of evidence used in the regulatory decision-making process (reasons behind special import authorization, i.e., products without valid MAs); 3) inconsistent and unsecured archiving system; 4) limited human resources; and 5) an inefficient information management system
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0164619 October 13, 2016
The product of all this work is the Standard Treatment Guideline and Essential Medicines List of Common Medical Conditions in the Kingdom of Swaziland. These systematically developed statements are designed to assist practitioners in making decision...
This technical note summarizes the consolidated guidelines and adapts them to the context of Latin America and the Caribbean, in order to adequately monitor the number of people on ART. For this purpose, guidance is presented on the indicators and the methodology to know more precisely the number of...
This report reviews and analyses the Affordable Medicines Programme, which was introduced in Ukraine in April 2017 to provide patients with improved access to 23 outpatient medicines for the treatme...
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatr...
Accessed Febr. 6, 2020
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o...
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...
This field study to measure access to and use of medicines was undertaken in GHANA in May-June 2008. The study assessed information on the socio-economic level of households, and access to and use of ... for acute and chronic conditions as well as opinions and perceptions about medicines. The survey was conducted in six regions. In each region, six reference public heath care facilities were selected among those participating in the Level II Facility Survey that was carried out in parallel. Within defined distances from each reference public health care facility, households were selected by purposive cluster sampling. A total of 1065 household respondents were interviewed by means of a structured paper questionnaire
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS function...
